Scientific paper - Original scientific paper
Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study
Diabetes Therapy, 9 (2018), 6; 2315-2324. https://doi.org/10.1007/s13300-018-0517-y


Cite this document

Baretić, M., Kušec, V. & Pavlić Renar, I. (2018). Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study. Diabetes Therapy, 9. (6), 2315-2324. doi: 10.1007/s13300-018-0517-y

Baretić, Maja, et al. "Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study." Diabetes Therapy, vol. 9, no. 6, 2018, pp. 2315-2324. https://doi.org/10.1007/s13300-018-0517-y

Baretić, Maja, Vesna Kušec and Ivana Pavlić Renar. "Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study." Diabetes Therapy 9, no. 6 (2018): 2315-2324. https://doi.org/10.1007/s13300-018-0517-y

Baretić, M., Kušec, V. and Pavlić Renar, I. (2018) 'Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study', Diabetes Therapy, 9(6), pp. 2315-2324. doi: 10.1007/s13300-018-0517-y

Baretić M, Kušec V, Pavlić Renar I. Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study. Diabetes Therapy [Internet]. 2018 December [cited 2024 October 05];9(6):2315-2324. doi: 10.1007/s13300-018-0517-y

M. Baretić, V. Kušec and I. Pavlić Renar, "Glucagon-like peptide-1 infusion suppresses aldosterone levels in healthy normal-weight individuals: double-blind, placebo-controlled crossover study", Diabetes Therapy, vol. 9, no. 6, pp. 2315-2324, December 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:346112. [Accessed: 05 October 2024]

Please login to the repository to save this object to your list.